Prince HM, Kim YH, Horwitz SM, Dummer R, Scarisbrick J, Quaglino P, et al 147. Brentuximab vedotin otherwise physician’s choice from inside the CD30-confident cutaneous T-phone lymphoma (ALCANZA): an international, open-identity, randomised, phase 3, multicentre